title: Extended-spectrum β-lactamases producing Klebsiella pneumoniae isolated in two hospitals in Goiânia/Brazil: detection, prevalence, antimicrobial susceptibility and molecular typing.
abstract: This study was developed to evaluate the prevalence of extended-spectrum β-lactamases (ESBL) producing Klebsiella pneumoniae in two hospitals (A and B) in Goiânia, GO, Brazil. The antimicrobial susceptibility of the isolates was determined using the MicroScan WalkAway (Dade Behring, USA). Tests to evaluate the genetic correlation between the isolates were also performed. For the ESBL phenotypic test, the Double-disk diffusion (DD) method was used. The strains isolated in Hospital B were submitted to DNA analysis by pulsed-field gel electrophoresis (PFGE). The study showed high prevalence of ESBL-producing K. pneumoniae (25% in hospital A and 66.7% in hospital B), with high rates of antimicrobial resistance. The most active compound was imipenem (100% susceptibility in vitro). The PFGE test showed similiarity in five strains and variability in six strains.The high prevalence of ESBL-producing Klebsiella may be due to individual selection and to dissemination of a common strain.
authors.affiliation: Universidade Católica de Goiás , Goiânia, GO , Brasil.
authors.forename: Daniella Fabíola
authors.initials: DF
authors.lastname: Dos Santos
authors.forename: Fabiana Cristina
authors.initials: FC
authors.lastname: Pimenta
authors.forename: Rodrigo
authors.initials: R
authors.lastname: Alves
authors.forename: Edlaine Rodrigues
authors.initials: ER
authors.lastname: Montalvão
authors.forename: Daniela Braz
authors.initials: DB
authors.lastname: Dos Santos
authors.forename: José Rodrigues
authors.initials: JR
authors.lastname: do Carmo Filho
keywords: Extended-spectrum β-lactamases (ESBL); Klebsiella pneumoniae; bacterial resistance; β-lactamases
references.citation: J Antimicrob Chemother. 2000 Mar;45(3):295-303
references.pmid: 10702547
references.citation: Chest. 2001 Feb;119(2 Suppl):391S-396S
references.pmid: 11171775
references.citation: Pharmacotherapy. 1999 Aug;19(8 Pt 2):120S-128S; discussion 133S-137S
references.pmid: 10456609
references.citation: Ann Clin Microbiol Antimicrob. 2004 Sep 15;3:17
references.pmid: 15369593
references.citation: Infect Control Hosp Epidemiol. 1997 Apr;18(4):275-91
references.pmid: 9131374
references.citation: Clin Infect Dis. 2004 Jul 1;39(1):31-7
references.pmid: 15206050
references.citation: Curr Clin Top Infect Dis. 1996;16:151-63
references.pmid: 8714252
references.citation: J Clin Microbiol. 2004 Jan;42(1):294-8
references.pmid: 14715768
references.citation: J Antimicrob Chemother. 2000 Jan;45(1):1-4
references.pmid: 10629005
references.citation: Infect Control Hosp Epidemiol. 2006 Jul;27(7):748-53
references.pmid: 16807852
references.citation: J Clin Microbiol. 2005 Sep;43(9):4891-4
references.pmid: 16145169
references.citation: Am J Infect Control. 2006 Jun;34(5 Suppl 1):S20-8; discussion S64-73
references.pmid: 16813978
references.citation: Drug Resist Updat. 2006 Jun;9(3):142-56
references.pmid: 16899402
references.citation: Chest. 2001 Feb;119(2 Suppl):405S-411S
references.pmid: 11171777
references.citation: Infect Control Hosp Epidemiol. 1996 Feb;17(2):129-40
references.pmid: 8835450
references.citation: JAMA. 1998 Oct 14;280(14):1233-7
references.pmid: 9786372
references.citation: Braz J Infect Dis. 2001 Aug;5(4):200-14
references.pmid: 11712965
references.citation: Diagn Microbiol Infect Dis. 2002 Nov;44(3):273-80
references.pmid: 12493175
references.citation: Chest. 2001 Feb;119(2 Suppl):426S-30S
references.pmid: 11171780
references.citation: Braz J Infect Dis. 2000 Apr;4(2):91-9
references.pmid: 10795074
references.citation: Braz J Infect Dis. 1997 Aug;1(4):196-203
references.pmid: 11105137
references.citation: J Clin Microbiol. 1995 Sep;33(9):2233-9
references.pmid: 7494007
references.citation: J Clin Microbiol. 1994 Mar;32(3):691-6
references.pmid: 8195380
references.citation: Clin Infect Dis. 2000 Jan;30(1):55-60
references.pmid: 10619733
references.citation: Chest. 2001 Feb;119(2 Suppl):371S-372S
references.pmid: 11171772
references.citation: Am J Med. 1996 Jun 24;100(6A):3S-12S
references.pmid: 8678095
references.citation: Antimicrob Agents Chemother. 1998 Jul;42(7):1850-2
references.pmid: 9661034